Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit

J Allergy Clin Immunol Pract. 2023 Feb;11(2):632-635. doi: 10.1016/j.jaip.2022.08.043. Epub 2022 Sep 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • COVID-19*
  • Drug Hypersensitivity* / therapy
  • Humans
  • Hypersensitivity*
  • Intensive Care Units
  • Penicillins / adverse effects

Substances

  • Penicillins
  • Anti-Bacterial Agents